Answers are grounded in this paper and cite their sources.
Endocardial fibroelastosis is an important cause of cardiac failure that must be distinguished from surgically correctable diseases, characterized by endocardial thickening and variable etiology.
Endocardial fibroelastosis (8, 36) is being recognized with increasing frequency and has now been described as a cause of cardiac failure and death in patients of all age groups (1, 3, 36). Other descriptive terms which have been used to designate this condition are “endocardial sclerosis” (2, 6, 9, 11), “endomyocardial fibroelastosis” (10, 17), “congenital fibroelastosis of the endocardium” (14), “fetal endocarditis” (16, 24, 32), “dilatation and hypertrophy of the heart” (23, 25, 35), “congenital diffuse endocardial hyperplasia” (28), “elastic tissue hyperplasia of the endocardium” (31), and “prenatal fibroelastosis” (32). It has been included, also, in the group of “primary myocardial diseases” (30). The significance of its recognition in the absence of any specific therapy (other than treatment directed toward cardiac failure in general) lies in the importance of distinguishing it from diseases which are amenable to surgery. Fibroelastic change in the endocardium is variable in degree but will usually be recognized on gross inspection of the endocardial surfaces, which show shiny gray-white thickening that may extend to and involve the valves. The left side of the heart is most often affected, chiefly the ventricle, where the endocardial thickening is greatest over the septal surface. This tends to obscure the prominence of the trabeculae carneae. Less often, and to a lesser degree, the right side of the heart is involved, either additionally (5, 6, 17) or by itself. Cardiac hypertrophy and dilatation are usually quite marked. The endocardial thickening is due to a heavy layer of elastic and collagen fibers which may extend into the myocardium for short distances about small blood vessels. No specific myocardial lesions are found, although changes ranging from patchy fibrosis to infarction have been described (6, 19, 20, 29, 34). Abnormal glycogen deposits are frequently present (19, 20, 29), and degenerative changes and calcifications are sometimes seen in muscle fibers underlying the thickened endocardium (8). The pericardium is normal in most cases. Pathologic changes in the lungs and other organs usually represent the effects of congestive heart failure. Mural thrombi, if present, may give rise to infarcts at distant sites. Reconstruction of the pathogenesis and determination of the specific etiology or etiologic factors important in the production of this change in a given patient are often difficult. Frequently the same histologic pattern is found in patients with coronary artery arteriosclerosis (34) and medial necrosis of the coronary arteries (30). It is typically present in endocardium poorly nourished because of anomalies of the coronary circulation, such as origin of the left coronary from the pulmonary artery (6, 7, 13, 26, 34), and is found also in hearts which, as a result of some mechanical or structural defect or because of an excessively high load, are subject to abnormal stresses (6, 9, 14, 27).
No takes yet. Share an insight, caveat, or question.
Eyler et al. (1955) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: